“…The majority of studies involving these devices and others, including the SonixGPS (UltraSonix, Richmond, BC, Canada) and Venue 50 (GE Healthcare, Chicago, IL, USA), have been pre-clinical in nature. [12][13][14][15][16][17] Two randomized studies using the SCENERGY and eZono 4000 (eZono, Jena, Germany) devices demonstrated 100% successful cannulation and no complications in use with adult patients; however, only the former showed a time-savings benefit 10,18 . Prior to this report, no such device has been studied in, specifically, the pediatric population.…”